Efficacy of Lentinula edodes Mycelia Extract on Chemotherapy-Related Tasted Disorders in Pancreatic Cancer Patients
Nutr Cancer. 2023; 75(1): 236-246.
Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study
Trials. 2022; 23(1): 135.
電気泳動. 2021; 65(2): 23-27.
Shajedul Islam, et al.
A standardized extract of cultured Lentinula edodes mycelia downregulates cortactin in gemcitabine‑resistant pancreatic cancer cells
Oncol Lett. 2021; 22(3): 654.
Nutritional impact of active hexose-correlated compound for patients with resectable or borderline-resectable pancreatic cancer treated with neoadjuvant therapy
Surg Today. 2021; 51(11): 1872-1876.
Anarkhuu Bold-Erdene, et al.
Clinical outcomes of active hexose correlated compound (AHCC®) and its effect on chemotherapy related adverse events in patients with unresectable pancreatic cancer
Diagnosis. 2018; 83(3): 56-60.
CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells
Anticancer Res. 2018; 38(11): 6107-6111.
Alleviating effect of Active Hexose Correlated Compound (AHCC) on chemotherapy-related adverse events in patients with unresectable pancreatic ductal adenocarcinoma
Nutr Cancer. 2016; 68(2): 234-40.
Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells
Anticancer Res. 2015; 35(11): 6063-7.
Active Hexose-correlated Compound Down-regulates Sex-determining Region Y-box 2 of Pancreatic Cancer Cells
Anticancer Res. 2014; 34(9): 4807-11.
Active Hexose-correlated Compound Down-regulates HSP27 of Pancreatic Cancer Cells, and Helps the Cytotoxic Effect of Gemcitabine
Anticancer Res. 2014; 34(1): 141-6.
Preventing Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy With Active Hexose-correlated Compound Derived From Lentinula edodes Mycelia
Integr Cancer Ther. 2022; 21: 15347354211073066.
Zhiyun Cao, et al.
Active hexose correlated compound potentiates the antitumor effects of low-dose 5-fluorouracil through modulation of immune function in hepatoma 22 tumor-being mice
Nutr Res Pract. 2015; 9(2): 129-36.
Long-term administration of Active Hexose Correlated Compound as a dietary supplement to a patient after breast cancer surgery and chemotherapy: A case report
Integr Cancer Sci Ther. 2017; 4(1).
Mehran Haidari, et al.
Disruption of endothelial adherens junction by invasive breast cancer cells is mediated by reactive oxygen species and is attenuated by AHCC.
Life Sci. 2013; 93(25-26): 994-1003.
Effect of Active Hexose-Correlated Compound in Women Receiving Adjuvant Chemotherapy for Breast Cancer: A Retrospective Study
J Altern Complement Med. 2013; 19(11): 905-10.
Retrospective Study in Breast Cancer Patients Supplemented with AHCC
Inte J Integr Oncol. 2009; 3(2): 12-16.
Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice
J Exp Ther Oncol. 2009; 8(1): 43-51.
Buxiang Sun, et al.
The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents
Cancer Epidemiol. 2009; 33(3-4): 293-9.
Active Hexose Correlated Compound (AHCC) Alleviates Gemcitabine-Induced Hematological Toxicity in Non-Tumor-Bearing Mice
Intern J Clin Med. 2012; 3: 361-367.
Jin Young Choia, et al.
Active Hexose Correlated Compound (AHCC) Inhibits the Proliferation of Ovarian Cancer Cells by Suppressing Signal Transducer and Activator of Transcription 3 (STAT3) Activation
Nutr Cancer. 2018; 70(1): 109-115.
Wineeya Suknikhom, et al.
The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer Receiving Platinum Based Chemotherapy
Asian Pac J Cancer Prev. 2017; 18(3): 633-638.
Dietary Administration of Mushroom Mycelium Extracts in Patients with Early Stage Prostate Cancers Managed Expectantly: A Phase II Study
Jpn J Clin Oncol. 2010; 40(10): 967-72.
Jeffrey Turner, et al.
Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer
Anticancer Drugs. 2009; 20(3): 215-6.
Francesca Paganelli, et al.
The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of LGR5 and Notch1 Genes in Cancer Stem Cells: A Novel Potential Approach for Integrative Medicine
Pharmaceuticals. 2021; 14(12): 1325.
Maiko Takahashi, et al.
Activation of NF-E2 p45-related factor-2 transcription and inhibition of intestinal tumor development by AHCC, a standardized extract of cultured Lentinula edodes mycelia
J Clin Biochem Nutr. 2019; 65(3): 203-208.
Hong-Jai Park, et al.
AHCC®, a standardized extract of cultured Lentinula edodes mycelia, promotes the anti-tumor effect of dual immune checkpoint blockade effect in murine colon cancer
Front Immunol. 2022; 13: 875872.
Personalized Cancer Therapy for Stage IV Lung Cancer: Combined Use of Active Hexose Correlated Compound and Genistein Concentrated Polysaccharide
Pers Med Univers. 2012; 1(1): 39-44.
Review of Cancer Therapy with AHCC(R) and GCP(R); The Long-Term Follow-Up over 12 Years for Stage IV (M1) Cancer of the Lung and the Breast
国際統合医学会誌. 2010; 2(1): 98-111.
Rodney J Hunter, et al.
Evaluation of active hexose correlated compound (AHCC) in combination with pegylated liposomal doxorubicin for treatment of ovarian cancer
Int J Appl Res Nat Prod. 2011; 4(3): 6-14.
Lata Mathew, et al.
Evaluation of Active Hexose Correlated Compound (AHCC) in Combination With Anticancer Hormones in Orthotopic Breast Cancer Models
Integr Cancer Ther. 2017; 16(3): 300-307.
Andrea Del Buono, et al.
Polysaccharide from Lentinus edodes for Integrative Cancer Treatment: Immunomodulatory Effects on Lymphocyte Population
World Cancer Research Journal. 2016; 3 (1): e652.
Improved Survival of Patients with Gastric Cancer or Colon Cancer when treated with Active Hexose Correlated Compound (AHCC): Effect of AHCC on digestive system cancer
Natural Medicine Journal. 2009; 1(1).
Kavin Fatehchand, et al.
Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells
PLoS One. 2017; 12(7): e0181729.
Dillip Kumar Parida, et al.
Integrating Complimentary and Alternative Medicine in Form of Active Hexose Correlated Compound (AHCC) in the Management of Head & Neck Cancer Patients
Intern J Clin Med. 2011; 2, 588-592.
Tamer A Badawi, et al.
Immunoprophylactic Effect of Active Hexose Correlated Compound on Normal and Induced Submandibular Salivary Gland Neoplasm in Albino Rats
Cairo Dental Journal. 2012; 28(1): 485-490.
Reduction of Adverse Effects by a Mushroom Product, Active Hexose Correlated Compound (AHCC) in Patients with Advanced Cancer during Chemotherapy-The Significance of the Levels of HHV-6 DNA in Saliva as a Surrogate Biomarker during Chemotherapy.
Nutr Cancer. 2014; 66(3): 377-82.
Émilie A Graham, et al.
MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC)
Cancer Biol Ther. 2017; 18(10): 765-774.
Bruna Corradetti, et al.
Bioactive Immunomodulatory Compounds: A Novel Combinatorial Strategy for Integrated Medicine in Oncology? BAIC Exposure in Cancer Cells
Integr Cancer Ther. 2019; 18: 1534735419866908.
Rosa Mistica Ignacio, et al.
Therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with CpG-ODN (oligodeoxynucleotide) in B16 melanoma murine model
Cytokine. 2015; 76(2): 131-137.